DarioHealth Corp Company Leadership

DRIO Stock  USD 11.55  0.00  0.00%   
DarioHealth Corp's insiders are aggressively buying. The analysis of the overall insider sentiment regarding DarioHealth Corp suggests that virtually all insiders are extremely bullish. DarioHealth Corp employs about 196 people. The company is managed by 23 executives with a total tenure of roughly 25 years, averaging almost 1.0 years of service per executive, having 8.52 employees per reported executive.
Erez Raphael  Chairman
Chairman, CEO and Pres
Olivier Jarry  President
President and Chief Commercial Officer

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2024-09-11Steven Charles NelsonAcquired 250 @ 16View
2024-09-09Steven Charles NelsonAcquired 250 @ 16View
2024-09-05Steven Charles NelsonAcquired 250 @ 16.4View
2024-08-27Erez RaphaelAcquired 250 @ 17.6View
Monitoring DarioHealth Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

DarioHealth Corp's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with DarioHealth Corp's future performance. Based on our forecasts, it is anticipated that DarioHealth will maintain a workforce of about 200 employees by March 2026.
 
Yuan Drop
 
Covid
 
Interest Hikes

DarioHealth Corp Management Team Effectiveness

The company has return on total asset (ROA) of (0.2143) % which means that it has lost $0.2143 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6342) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of February 2026, Return On Tangible Assets is likely to drop to -0.95. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, DarioHealth Corp's Fixed Asset Turnover is very stable compared to the past year. As of the 17th of February 2026, Asset Turnover is likely to grow to 0.35, while Total Current Assets are likely to drop about 24.5 M.
As of the 17th of February 2026, Common Stock Shares Outstanding is likely to grow to about 81.1 M, though Net Loss is likely to grow to (53.2 M). The market capitalization of DarioHealth Corp is $79.21 Million. DarioHealth Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2012-03-31
Previous Quarter
49.6 M
Current Value
49.6 M
Avarage Shares Outstanding
11.4 M
Quarterly Volatility
16.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as DarioHealth Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DarioHealth Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

DarioHealth Corp Workforce Comparison

DarioHealth Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 11,681. DarioHealth Corp claims roughly 196 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (1.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.89.

DarioHealth Corp Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DarioHealth Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on DarioHealth Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DarioHealth Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
 
Interest Hikes
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2022-06-01
10.0
10
1
 920,000 
 17,957 
2021-12-01
0.25
3
12
 1,421 
 140,006 
2021-09-01
1.3333
4
3
 21,406 
 14,800 
2021-06-01
1.5
3
2
 1,376 
 67,787 
2021-03-01
26.0
26
1
 1,745,904 
 0.00 
2020-09-01
4.8
24
5
 400,549 
 291,198 
2020-03-01
27.0
27
1
 931,321 
 0.00 
2019-12-01
1.375
11
8
 46,127 
 582,396 
2018-09-01
6.5
13
2
 168,255 
 0.00 
2017-12-01
4.3333
13
3
 1,077,327 
 1,785,716 
2017-09-01
1.7143
12
7
 77,248 
 957,940 
2017-03-01
20.0
20
1
 660,986 
 0.00 
2016-03-01
0.303
10
33
 592,245 
 762,893 

DarioHealth Corp Notable Stakeholders

A DarioHealth Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DarioHealth Corp often face trade-offs trying to please all of them. DarioHealth Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DarioHealth Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Erez RaphaelChairman, CEO and PresProfile
Steven NelsonPresident OfficerProfile
Olivier JarryPresident and Chief Commercial OfficerProfile
Zvi CPATreasurer CFOProfile
Chen FrancoYehudaTreasurer CFOProfile
Zoe HarrisonVP DevelopmentProfile
Rob HalpernSVP MarketingProfile
Lara DodoChief OfficerProfile
Michal AbermanShimonChief OfficerProfile
Tomer BenKikiChief OfficerProfile
Josh FischerSenior ComplianceProfile
Dov OppenheimCoFounder ChiefProfile
Brian HarriganSenior SalesProfile
Richard AndersonPresidentProfile
Claudia LeviContent ManagerProfile
Jean MuylHead AmericaProfile
Zvi DavidTreasurer CFOProfile
Kat ParrellaInvestor ManagerProfile
Dror BacherChief OfficerProfile
Mona DeanChief OfficerProfile
Mary MooneyVice MarketingProfile
Limor DreznerChief OfficerProfile
Omar MDChief OfficerProfile
String symbol = request.getParameter("s");

About DarioHealth Corp Management Performance

The success or failure of an entity such as DarioHealth Corp often depends on how effective the management is. DarioHealth Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DarioHealth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DarioHealth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.90)(0.95)
Return On Capital Employed(0.51)(0.53)
Return On Assets(0.32)(0.34)
Return On Equity(0.68)(0.65)

DarioHealth Corp Workforce Analysis

Traditionally, organizations such as DarioHealth Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DarioHealth Corp within its industry.

DarioHealth Corp Manpower Efficiency

Return on DarioHealth Corp Manpower

Revenue Per Employee138K
Revenue Per Executive1.2M
Net Loss Per Employee218.1K
Net Loss Per Executive1.9M
Working Capital Per Employee121.9K
Working Capital Per Executive1M
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Health Care Technology sector continue expanding? Could DarioHealth diversify its offerings? Factors like these will boost the valuation of DarioHealth Corp. Projected growth potential of DarioHealth fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DarioHealth Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(10.87)
Revenue Per Share
8.268
Quarterly Revenue Growth
(0.33)
Return On Assets
(0.21)
Return On Equity
(0.63)
DarioHealth Corp's market price often diverges from its book value, the accounting figure shown on DarioHealth's balance sheet. Smart investors calculate DarioHealth Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since DarioHealth Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between DarioHealth Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DarioHealth Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.